secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0000950170-24-120188
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics extends poison pill expiration to Oct 2025, adjusts purchase price to $70
--------------------------------------------------------------------------------

- Amendment No. 4 extends Rights Agreement Final Expiration Date to October 31, 2025.
- Purchase Price changed to $70 per one one-thousandth of a Series A Preferred Share.
- Rights Agreement originally dated November 8, 2020; Amendment modified rights of security holders.
- Entered into with Broadridge Corporate Issuer Solutions as Rights Agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024120188/0000950170-24-120188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024120188/apvo-20241101.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-120188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer